Why the study?
Does continuous spinal anaesthesia with bupivacaine improve haemodynamic stability compared to single-dose spinal anaesthesia in elderly patients undergoing orthopaedic surgery?
Does continuous spinal anaesthesia with bupivacaine improve haemodynamic stability compared to single-dose spinal anaesthesia in elderly patients undergoing orthopaedic surgery?
Titration of bupivacaine for continuous spinal anaesthesia causes minor haemodynamic changes that are similar to those seen with single-dose spinal bupivacaine.
Answers are grounded in this paper and cite their sources.
Similar haemodynamic changes observed with both techniques; hypothesis-generating and should not yet change practice.
Forty elderly patients, scheduled for orthopaedic surgery of the hip or knee were studied. Twenty patients received a single-dose spinal anaesthesia with 3 ml of plain 0.5% bupivacaine (SDSA group). Twenty patients received continuous spinal anaesthesia using a 32- or 22-gauge catheter. A bolus of 1.0 ml of plain 0.5% bupivacaine was given to ten patients and 0.5 ml to another ten, continued by an infusion at a rate of 2 ml/h. The spread of analgesia and haemodynamic changes (central venous pressure, arterial pressures, need for sympathomimetic medication) were registered. The mean dose of bupivacaine was 2.9 ml (range 1.5-5 ml) in the CSA group (3.0 ml in the SDSA group). Eight patients in the CSA group needed medication for pain during surgery compared to five patients in the SDSA group (n.s.). The median level of pinprick analgesia at 60 min was T11 in the CSA and T6.5 in the SDSA group (P less than 0.01). The mean maximum decreases in CVP and MAP were quite similar in the CSA and SDSA group (2.1 vs 2.8 mmHg (0.3 vs 0.4 kPa) and 17 vs 21 mmHg (2.3 vs 2.8 kPa), respectively) (n.s.). Six patients in the SDSA group and four patients in the CSA group needed sympathomimetic medication. It is concluded that titration of bupivacaine for spinal anaesthesia caused only minor haemodynamic changes which were similar to those after single-dose spinal bupivacaine.
No takes yet. Share an insight, caveat, or question.
Pitkänen et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: